Results The aggregate estimated hazard ratio comparing combination therapy with
angiotensin-converting enzyme inhibitors/angiotensin receptor blockers and SGLT2 inhibitor …

Progressive segmental glomerulosclerosis is acknowledged as a characteristic of Chronic
Kidney Disease (CKD). It is a major health issue that exponentially reduces health and …

Community acquired and hospital acquired AKI - two diseases... : Current Opinion in
Nephrology and Hypertension Community acquired and hospital acquired AKI - two diseases …

Background Chronic kidney disease (CKD) is common but heterogenous and is associated
with multiple adverse outcomes. The National Unified Renal Translational Research …

(1) Background: Hyperphosphatemia is correlated with an increased rate of mortality and
morbidity due to cardiovascular diseases in chronic kidney disease (CKD) patients. It can be …

Background Chronic kidney disease (CKD) is a significant public health problem. The
burden of CKD in children and adolescents in India is not well described. We used data from …

Background. There is no robust evidence–based data for ABO-incompatible kidney
transplantation (ABOiKT) from emerging countries. Methods. Data from 1759 living donor …

Introduction Angiotensin-converting enzyme inhibitors (ACEI) and angiotensin receptor
blockers (ARB) are the antihypertensive drug class of choice in patients with chronic kidney …

Background Although cardiovascular morbidity and mortality are substantial in patients with
chronic kidney disease (CKD), guideline-directed treatment of cardiovascular risk factors …

Abstract Chronic Kidney Disease (CKD) afflicts approximately 20% of the global population,
underscoring the pressing need for precise detection and diagnosis. Accurate kidney …